Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Amortization of Deferred Charges (2020 - 2025)

Mirum Pharmaceuticals has reported Amortization of Deferred Charges over the past 5 years, most recently at $436000.0 for Q4 2025.

  • Quarterly results put Amortization of Deferred Charges at $436000.0 for Q4 2025, up 4.81% from a year ago — trailing twelve months through Dec 2025 was $1.7 million (up 4.7% YoY), and the annual figure for FY2025 was $1.7 million, up 4.7%.
  • Amortization of Deferred Charges for Q4 2025 was $436000.0 at Mirum Pharmaceuticals, down from $443000.0 in the prior quarter.
  • Over the last five years, Amortization of Deferred Charges for MIRM hit a ceiling of $443000.0 in Q3 2025 and a floor of -$285000.0 in Q4 2021.
  • Median Amortization of Deferred Charges over the past 4 years was $411000.0 (2023), compared with a mean of $301133.3.
  • Biggest five-year swings in Amortization of Deferred Charges: plummeted 456.25% in 2021 and later surged 32.57% in 2024.
  • Mirum Pharmaceuticals' Amortization of Deferred Charges stood at -$285000.0 in 2021, then soared by 240.0% to $399000.0 in 2023, then grew by 4.26% to $416000.0 in 2024, then grew by 4.81% to $436000.0 in 2025.
  • The last three reported values for Amortization of Deferred Charges were $436000.0 (Q4 2025), $443000.0 (Q3 2025), and $427000.0 (Q2 2025) per Business Quant data.